The injectable medication, originally prescribed to treat wet macular degeneration ( a disease of the eye that results in a loss of vision at the center of the field of vision when blood vessels abnormally leak fluid into the macula ) was approved for expanded use in late July.
DiabetesHealth – Eylea earns FDA approval To Treat Diabetic Macular Edema
Posted in Drugs